Skip to content
Screener

Evolus EOLS Contingent milestone payment

Contingent milestone payment at other companies

Climb Bio, Inc. logo
Climb Bio, Inc.CLYM
$8M
Savara logo
SavaraSVRA
$573K+5.9%
Rivian Automotive, Inc. logo
Rivian Automotive, Inc.RIVN
$1B0.0%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$4M
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$500K
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$77M0.0%

Other financials

Income statement

See full
Revenue$84.1M+21.2%
Gross profit$57.2M+26.2%
Operating income-$4.5M+55.5%
Net income-$8.1M+53.0%
EPS (diluted)-$0.12+55.6%

Balance sheet

See full
Cash & equivalents$45.2M-26.8%
Total debt$164.8M+12.3%
Total equity-$30.9M-65.7%
Total assets$248.0M+8.4%

Cash flow

See full
Operating cash flow-$3.6M+85.5%
CapEx$50.0K-92.7%
Free cash flow-$3.6M+85.7%

Valuation

See full
Market cap$406.98M-1.2%
Enterprise value$526.62M+6.0%
P/S1.3×-0.2×

Profitability

See full
Gross margin66.7%-0.4pp
Operating margin-13.7%-1.9pp
Net margin-10.9%-3.7pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×
Current ratio1.7×-0.6×

Where this comes from

Reported directly by Evolus in its filing.

Tagged under the XBRL concept eols:LicenseSupplyAndDistributionAgreementContingentMilestoneLiabilityNoncurrent.

The source filing: Evolus’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:56 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053468
Line itemJune 30, 2026December 31, 2025
Long-term portion of operating lease liabilities5,4876,371
Long-term portion of contingent royalty obligation payable to Evolus Founders16,40619,659
Long-term debt156,744146,096
Long-term portion of contingent milestone payment1,5441,515
Deferred tax liability1528
Total liabilities$278,927$248,974
Commitments and contingencies (Note 9)
Stockholders’ equity (deficit)

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Evolus's contingent milestone payment?
Evolus (EOLS) reported contingent milestone payment of $1.54M in Q2 2026.
How has Evolus's contingent milestone payment changed year-over-year?
Evolus's contingent milestone payment decreased by 42.4% year-over-year, from $2.68M to $1.54M.
What does contingent milestone payment mean?
Contingent milestone payment as reported by Evolus, Inc. Common Stock.

Ask your AI about Evolus's contingent milestone payment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude